PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 175 filers reported holding PRECIGEN INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $766,977 | -28.3% | 504,590 | 0.0% | 0.00% | – |
| Q3 2022 | $1,069,731 | +58.2% | 504,590 | 0.0% | 0.00% | – |
| Q2 2022 | $676,151 | -36.5% | 504,590 | 0.0% | 0.00% | – |
| Q1 2022 | $1,064,685 | -43.1% | 504,590 | 0.0% | 0.00% | – |
| Q4 2021 | $1,872,000 | -25.7% | 504,590 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $2,518,000 | -5.2% | 504,590 | +23.9% | 0.00% | 0.0% |
| Q2 2021 | $2,655,000 | -5.4% | 407,266 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,806,000 | -32.5% | 407,266 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,154,000 | +368.3% | 407,266 | +60.7% | 0.00% | – |
| Q3 2020 | $887,000 | -34.7% | 253,451 | -6.9% | 0.00% | – |
| Q2 2020 | $1,358,000 | +29.7% | 272,201 | -11.6% | 0.00% | – |
| Q1 2020 | $1,047,000 | – | 307,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |